Red Cross Hit With Antitrust Suit For Platelet Treatment Tying
The American Red Cross has been accused by a biotech company of launching an illegal campaign to "smother" competition in the platelet bacteria mitigation market by tying its platelet sales to...To view the full article, register now.
Already a subscriber? Click here to view full article